Ligustrazine Hydrochloride for Injection
Function and Efficacy
Ligustrazine hydrochloride has an inhibitory effect on human platelet aggregation induced by adenosine diphosphate (ADP), arachidonic acid and PAF (platelet activating factor), and has a depolymerizing effect on aggregated platelets. In addition, this product can also dilate arterioles, improve microcirculation and increase cerebral blood flow.
Ingredients
Ligustrazine hydrochloride. Chemical name: 2,3,5,6-tetramethylpyrazine hydrochloride dihydrate.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| Ligustrazine HydrochlorideIngredients |
It has an inhibitory effect on human platelet aggregation induced by adenosine diphosphate (ADP), arachidonic acid and PAF (platelet activating factor), and has a depolymerizing effect on aggregated platelets. In addition, it can dilate arterioles, improve microcirculation and increase cerebral blood flow. More |
76494-51-4 | 12 |
Appearance
This product is white loose mass or powder.
Indication
1. Cardiovascular diseases: hypertension, coronary heart disease, unstable angina, etc. 2. It has good curative effect on the acute stage, recovery stage and sequelae of ischemic cerebrovascular disease, such as cerebral insufficiency, cerebral thrombosis, cerebral embolism, cerebral arteriosclerosis, etc., and can improve the symptoms of hemiplegia, aphasia, dysphagia, limb numbness, weakness, headache, dizziness, insomnia, tinnitus, unsteady walking, memory loss, etc. caused by these diseases. 3. Respiratory system diseases: cor pulmonale, pulmonary hypertension, emphysema, pulmonary fibrosis, chronic respiratory failure, pediatric pneumonia, etc. 4. Others: vertigo, chronic renal failure, epidemic hemorrhagic fever, chronic active hepatitis, cervical spondylosis, sudden deafness, purpuric nephritis.
Usage and Dosage
120 mg at a time, diluted in 250ml~500ml glucose solution or normal saline for intravenous drip, once a day, generally 10-14 days as a course of treatment, or as directed by a doctor.
Adverse Reactions
Occasionally, there may be dry mouth, drowsiness, etc.
Precautions
The following patients are contraindicated: 1. Those who are allergic to this product. 2. Those with cerebral hemorrhage or bleeding tendency.
Special Population Medication
Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Those with obvious heart, liver, and kidney function impairment should reduce the dosage as appropriate.
Drug Interactions
Not yet clear.
Storage
Store in a cool place.
Packaging Specification
40mg
Validity Period
18 months
Manufacturer
Harbin Medisan Pharmaceutical Co., Ltd.
-
Founded in:
1996-06-21 -
Address:
Beijing Road, Limin Development Zone, Harbin -
Tax NO.:
91230100607168790X -
Registered Funds:
316.35755 million yuan -
Website:
-
Email: